Literature DB >> 23433108

Mouse models of polycystic kidney disease induced by defects of ciliary proteins.

Je Yeong Ko1, Jong Hoon Park.   

Abstract

Polycystic kidney disease (PKD) is a common hereditary disorder which is characterized by fluid-filled cysts in the kidney. Mutation in either PKD1, encoding polycystin-1 (PC1), or PKD2, encoding polycystin-2 (PC2), are causative genes of PKD. Recent studies indicate that renal cilia, known as mechanosensors, detecting flow stimulation through renal tubules, have a critical function in maintaining homeostasis of renal epithelial cells. Because most proteins related to PKD are localized to renal cilia or have a function in ciliogenesis. PC1/PC2 heterodimer is localized to the cilia, playing a role in calcium channels. Also, disruptions of ciliary proteins, except for PC1 and PC2, could be involved in the induction of polycystic kidney disease. Based on these findings, various PKD mice models were produced to understand the roles of primary cilia defects in renal cyst formation. In this review, we will describe the general role of cilia in renal epithelial cells, and the relationship between ciliary defects and PKD. We also discuss mouse models of PKD related to ciliary defects based on recent studies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23433108      PMCID: PMC4133850          DOI: 10.5483/bmbrep.2013.46.2.022

Source DB:  PubMed          Journal:  BMB Rep        ISSN: 1976-6696            Impact factor:   4.778


INTRODUCTION

Polycystic kidney disease (PKD) is a common genetic disorder and is manifested by defects in renal ithelial cells, resulting in an increase of cell proliferation and cyst formation (1). PKD is a systemic disorder which is characterized by cysts in thekidney, liver and pancreas (2). ADPKD is caused by mutations of either PKD1 (85%) or PKD2 (15%) genes, which encode polycystin-1 (PC1) or polycystin-2 (PC2) respectively (3). PC1 is a large integral membrane protein, which includes a long N-terminal extracellular domain, a short C-terminal intracellular domain, and eleven transmembrane domains, and acts as a G-protein-coupled receptor (4-6). PC1 is localized to primary cilia, lateral domain of the plasma membrane (7), and regions of cell-matrix interaction (8). The C-terminal, cytoplasmic tail, of PC1 is cleaved to generate products, which interact with transcription factors. PC2 is a membrane protein with six transmembrane domains, and is considered to be a cation channel with specificity for calcium (9,10). This protein is localized to not only primary cilia (11), but also to subcellular compartments, including the plasma membrane (12) and endoplasmic reticulum. PC1 and PC2 interact via their C-terminus (13) to form transmembrane receptor-ion channel complex in the primary cilia of renal epithelial cells (1,14). This protein complex regulates intracellular calcium levels through its channel, which is stimulated by fluid flow in the renal tubule, and affects calcium-related pathways. Recent studies have shown that dysfunctions of PC1 and PC2 result in decreased intracellular calcium in renal epithelial cells of PKD (15). Some aberrant signaling pathways have been identified in PKD. Among these, the signaling pathway related to calcium, cyclic AMP (cAMP) and mammalian target of rapamycin (mTOR) is well-known as a major signaling in PKD (16-19). In addition to these pathways, dysregulation of cell cycle, JAK-STAT pathway, canonical and non-canonical Wnt pathway are observed in PKD. Recent studies suggest that defects of primary cilia are also related to the formation of renal cystic kidneys (20,21). The cilium acts as a mechanosensor in kidney tubules, in regulating homeostasis of renal epithelial cells. Many signaling components are localized to the membrane of renal primary cilia. Accumulating results show that proteins related to PKD are localized to the primary cilia, and disruptions of ciliary proteins, including intraflagellar transport (IFT), induce PKD (3). These findings indicate that defects of cilia act as a driving force to induce PKD (22). Consistent with these recent findings, malfunctions of primary cilia, induced by mutations of ciliary proteins, is correlated with PKD. Therefore, it is important to identify the cyst formation mechanism associated with ciliary malfunctions using in vivo studies, to develop therapeutic targets for PKD. Here, we will focus on recent advances in understanding the ciliary roles in polycystic kidney and PKD mouse models accompanied by cilia defects.

PRIMARY CILIA AND IFT

The cilium is commonly divided into two groups, motile and non-motile cilia. Motile cilia that have a 9+2 microtubule configuration (3) are mainly located on epithelial cells, and promote the movement of substances. On the other hand, non-motile cilia, known as primary cilia, have a 9+0 microtubule arrangement. Primary cilia projected from the cell membrane act as mechanosensor to sense mechanical forces, growth factors and chemical compounds from extracellular environments (23). Primary cilia have important roles for regulating intracellular signaling, such as Hedgehog (Hh), Wnt, platelet- derived growth factor receptor (PDGFR) α, and mechanosignaling related to PKD1/2 complex (24). Regulation of ciliogenesis is critical to maintain functional cilia. The key factor related to ciliogenesis is Intraflagellar Transport (IFT), which is a bi-directional movement multi-protein complex (25). IFT particles are divided into two complexes, A and B. The complex A, known as retrograde transport, moves from ciliary tip to base with dynein, while the complex B, known as anterograde transport, moves from base to ciliary tip with kinesin-2 (26). IFT particles are regarded as vehicles for transporting cargos to regulate cilia assembly, maintenance, and function (27). In addition, these particles have a function in carrying cilia membrane proteins. Consistent with these roles for cilia, cilia defects or mutations of IFT genes are related to human disease, such as PKD, left-right asymmetry defects, cancer, and Bardet-Biedl syndrome (BBS) (24,28).

RELATIONSHIP BETWEEN CILIA DEFECTS AND POLYCYSTIC KIDNEY DISEASE

In renal epithelial cells, primary cilia protrude into lumen of the renal tubules to sense fluid flow (29). Polycystin-1 (PC1) and polycystin-2 (PC2) are localized to the membrane of cilium, and form a PC1/PC2 complex as a calcium channel. PC1 acts as mechanosensor to detect the bending of cilium induced by flow stimulation that transmits extracellular signals to PC2, which, in turn, induces Ca2+ influx to cytosol (11, 30), hence this complex and primary cilia in renal cells regulates intracellular signaling associated with calcium concentration such as the Raf/MEK/ERK pathway, which are increased in PKD (31). Moreover, various signaling molecules related to Hh, PDGFRα, and calcium signaling are localized to the cilia membrane (32). Therefore, defects of cilia or ciliary proteins are sufficient to induce pathological disorders. Among various diseases, PKD is one which is related to cilia defects. Many proteins whose functions are disrupted in PKD are localized to cilium membrane or to the ciliary basal body (24,33). Also, disruption of cilia proteins are involved in calcium signaling related to PKD, implicating a relationship between ciliary signaling and cyst formation (34). Consistent with this, the intracellular calcium level is decreased in PKD epithelial cells compared to normal renal epithelial cells (35). Recent studies have demonstrated that malfunction of renal cilia induces intracellular cAMP, leading to an increase of renal cell proliferation through the Raf/MEK/ERK pathway, known as a hallmark of cystic kidney (36,37). Therefore, to elucidate the functions of ciliary genes in vivo is important to identify the disease inducing mechanisms and therapeutic targets of PKD.

MOUSE MODELS OF POLYCYSTIC KIDNEY INDUCED BY MUTATIONS OF CILIARY PROTEINS

Kidney specific inactivation of Pkd1

As we described above, PC1 localized to primary cilia is a major causative gene for the development of polycystic kidneys. In the case of complete knockout of Pkd1 in the mouse, a complex embryonic lethality is observed: defects in formation of the kidney, pancreas, heart and capillary blood vessels (38-40). However, Pkd1 mice generated by deletion of exons 2-4 by Ksp-Cre are born, but consistently develop cystic kidneys (14). Consistent with this, components related to the MAPK/ERK pathway, blood urea nitrogen (BUN), and cell proliferation, are dramatically increased in the cystic kidney of this mouse (14).

Pkd2ws25/- mice

The WS25 allele is generated by the integration of an exon 1 disrupted by introduction of a neor cassette into intron 1 of Pkd2, without replacement of the wild-type exon 1 (41,42). This mutation causes an unstable allele, which increases the somatic mutation rate of Pkd2 (42,43). The knockout of Pkd2 is embryonically lethal between embryonic day 13.5 and parturition, whereas the Pkd2ws25/- mouse is born (44). The Pkd2ws25/- mouse is an animal model of ADPKD with hepatic cysts and cardiac defects, and exhibits renal failure (44). Studies using this mouse model have shown that renal cilia in the cystic kidney of Pkd2ws25/- mouse have normal phenotype (45), but cilia of cystic cholangiocytes are short and malformed (46).

Oak ridge polycystic kidney mice

The oak ridge polycystic kidney (ORPK) mouse resembles human ARPKD with respect to cystic kidneys and hepatic disease (47,48). This mouse is the first model showing a relationship between polycystic kidney and ciliary malfunction (48,49). The orpk allele was driven by insertion mutation on the intron near the 3’end of the gene, partially disrupting the function and expression of Ift88 (Tg737, polaris) (50). Increased levels of PC2 in primary cilia is observed in the kidneys of ORPK mice (49). The Tg737orpk mutant mice have polycystic kidneys with shortened cilia on renal epithelial cells (47,48). In addition to renal disorder, hepatic and pancreatic defects, skeletal patterning abnormalities and hydrocephalus are observed in the ORPK mouse (51-53).

Deletion of Ift20 in the mouse kidney

Inactivation of Ift20 in the mouse kidney using Cre-loxP system promotes postnatal cystic kidneys lacking cilia (54). The conditional allele of Ift20 was generated by targeting exon 2 and 3 (54). Deletion of Ift20 in kidneys collecting duct cells induces mis-orientation of the mitotic spindle and increases of canonical Wnt signaling, leading to increased renal cell proliferation (54). In addition to this in vivo study, there are some evidences showing that Ift20 is a candidate gene related to PKD. Ift20 is associated with Golgi complex to regulate cilia assembly and is involved in the localization of PC2 to cilia (55).

Mice with a conditional allele for Ift140

Deletion of Ift140, subunit of IFT complex A, in renal collecting duct cells leads to renal cyst formation with disruption of the cilia assembly, but this mutation does not have a function on mitotic spindle orientation (56). Several genes which are hallmarks of polycystic kidney and are associated with the canonical Wnt pathway, Hedgehog, Hippo and fibrosis were significantly increased in Ift140-deleted kidneys (56).

Kif3α-targeted mouse

Constitutive knockout of Kif3α, a subunit of kinesin-II that is critical for ciliogenesis, results in an absence of cilia in the embryonic node, situs inversus, and abnormalities of the neural tube, pericardium and smites (57,58). This constitutive Kif3α knockout mouse shows embryonic lethality before renal organogenesis (59). In contrast, in the case of specific targeting of Kif3α in renal tubular epithelial cells, viable offspring were born and developed cystic kidneys (59). These cystic lining epithelial cells have no cilia due to Kif3α inactivation, and show increased proliferation, apoptosis, expression of β-catenin, c-Myc, and decreased p21cip1 (59).

Congenital polycystic kidney mouse

The Cystin encoded by Cys1 is a 145-amino acid cilium-associated protein (60). The congenital polycystic kidney (cpk) mice have mutations of Cystin localized to the primary cilia (61-64). This mutant develops renal cysts and biliary dysgenesis and is considered as ARPKD (61). The kidneys of cpk/cpk mice have multiple cellular and extracellular abnormalities (63), including increased expression of proto-oncogenes, such as c-myc, c-fos (65,66), elevated expression of growth factors (67), abnormal expression of genes related to cell adhesion (68), and overexpression of matrix metalloproteinases (MMPs) (69). The renal cystic epithelial cells of cpk mice have different length and morphology of cilia (70).

Inversin-targeted mice

The Inversin protein localizes to the primary cilia, cell junctions and nucleus, and acts as a regulator of β-catenin activity and canonical Wnt pathway (71). The inversion of embryonic turning (inv) mutation is generated by random insertion of tyrosinase minigene in the OVE210 transgenic line (72,73). This random insertion disrupts Inversin encoded by Invs, which localizes to primary apical cilia (74). Phillips et al. (75) have demonstrated that normal looking monocilia were observed in cystic kidneys of inv/inv mice. However, the inv mutant shows a reversal of left-right asymmetry, and renal cyst known as diseases induced by ciliary defects (76).

Bbs2-deficient mice

The proteins encoded by Bardet-Biedl syndrome (BBS) genes, except for BBS6, are localized to ciliated organisms (77,78). BBS2 is one of the proteins that form the complex BBSome, which is localized to the membrane of the cilium and is required for ciliogenesis. Several evidences suggest that BBS4 and BBS6 are expressed in basal bodies of primary cilia (79,80). The ciliogenic function of the BBS complex is related to the Rab8 GDP/GTP exchange factor, which localizes to basal body and contacts the BBSome (81). Bbs2-deficient mice are generated by deletion of exons 5-14, and show the phenotype of cystic kidneys (82). Interestingly, renal cilia are observed in Bbs2-deficient mice, but their shape is abnormal compared to cilia of wild-type kidneys (82). In addition to polycystic kidney, this mutant mouse develops retinal degeneration, obesity and olfactory dysfunction (82).

Juvenile cystic kidney mouse

The jck allele has a missense mutation in the NIMA (never in mitosis A)-related kinase 8 encoded by Nek8 (83). NIMA is a serine/threonine kinase in Aspergillus nidulans, and has a function in regulating mitosis (84). Published results suggest that Nek8 is overexpressed in human breast cancers, indicating that Nek8 has a role in cell proliferation (84,85). In wild-type kidney, Nek8 is found in the proximal region of renal cilia, whereas kidneys of the jck mutant show that Nek8 is localized to the entire length of renal cilia (84). The kidneys of jck mice have cysts in multiple nephron segments like ADPKD, and increased cAMP levels, which promote renal cell proliferation and fluid secretion (86). Also, the lengthened cilia with overexpression of polycystins are observed in kidneys of jck mice (86).

CONCLUSION

The role of the renal primary cilia is under the spotlight, because the disruption of ciliary structures and proteins is associated with polycystic kidney. To determine the mechanism between defects of renal cilia and polycystic kidneys, various cystic kidney mouse models have been generated. Based on many studies, mutation of some proteins localized to primary cilia, such as IFT, leads to cyst formation accompanied by ciliary defects. This mechanism of cyst formation seems to occur via increased renal cell proliferation. Consistent with this, mutations of some proteins localized to ciliary membrane, such as PC1 and PC2, result in the development of cystic kidneys. However, these ciliary membrane proteins, non-IFT family proteins, which act as receptor and signaling molecules, seem to have no effect on the regulation of ciliogenesis. Instead of functioning in ciliogenesis, these proteins are localized to ciliary membranes to regulate the cilia function as mechanosensors rather than regulating ciliogenesis. Taken together, dysfunctions of proteins associated with renal primary cilia have an effect on cyst formation of the kidneys (Fig. 1). To identify the exact mechanism of cyst formation induced by ciliary defects, further in vivo studies are needed. It is important to reveal the mechanism of cystic kidney development, because a successful treatment for PKD has not yet been developed. Therefore, we expect that these mechanism studies might be used for the selection of novel therapeutic targets of PKD.
Fig. 1.

Localization of ciliary proteins related to polycystic kidney. Many proteins localized to renal cilia are associated with PKD. Disruptions of these proteins induce cystic kidneys through various signaling pathway.

  86 in total

1.  Bending the MDCK cell primary cilium increases intracellular calcium.

Authors:  H A Praetorius; K R Spring
Journal:  J Membr Biol       Date:  2001-11-01       Impact factor: 1.843

2.  Expression analyses and interaction with the anaphase promoting complex protein Apc2 suggest a role for inversin in primary cilia and involvement in the cell cycle.

Authors:  David Morgan; Lorraine Eley; John Sayer; Tom Strachan; Laura M Yates; A Scott Craighead; Judith A Goodship
Journal:  Hum Mol Genet       Date:  2002-12-15       Impact factor: 6.150

3.  Polycystin-2 localizes to kidney cilia and the ciliary level is elevated in orpk mice with polycystic kidney disease.

Authors:  Gregory J Pazour; Jovenal T San Agustin; John A Follit; Joel L Rosenbaum; George B Witman
Journal:  Curr Biol       Date:  2002-06-04       Impact factor: 10.834

4.  Kidney-specific inactivation of the KIF3A subunit of kinesin-II inhibits renal ciliogenesis and produces polycystic kidney disease.

Authors:  Fangming Lin; Thomas Hiesberger; Kimberly Cordes; Angus M Sinclair; Lawrence S B Goldstein; Stefan Somlo; Peter Igarashi
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-02       Impact factor: 11.205

5.  Constitutive activation of G-proteins by polycystin-1 is antagonized by polycystin-2.

Authors:  Patrick Delmas; Hideki Nomura; Xiaogang Li; Montaha Lakkis; Ying Luo; Yoav Segal; Jose M Fernández-Fernández; Peter Harris; Anna-Maria Frischauf; David A Brown; Jing Zhou
Journal:  J Biol Chem       Date:  2002-01-10       Impact factor: 5.157

6.  A defect in a novel Nek-family kinase causes cystic kidney disease in the mouse and in zebrafish.

Authors:  Shanming Liu; Weining Lu; Tomoko Obara; Shiei Kuida; Jennifer Lehoczky; Ken Dewar; Iain A Drummond; David R Beier
Journal:  Development       Date:  2002-12       Impact factor: 6.868

7.  Cystin, a novel cilia-associated protein, is disrupted in the cpk mouse model of polycystic kidney disease.

Authors:  Xiaoying Hou; Michal Mrug; Bradley K Yoder; Elliot J Lefkowitz; Gabriel Kremmidiotis; Peter D'Eustachio; David R Beier; Lisa M Guay-Woodford
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

8.  Polaris, a protein disrupted in orpk mutant mice, is required for assembly of renal cilium.

Authors:  Bradley K Yoder; Albert Tousson; Leigh Millican; John H Wu; Charles E Bugg; James A Schafer; Daniel F Balkovetz
Journal:  Am J Physiol Renal Physiol       Date:  2002-03

9.  The polycystic kidney disease proteins, polycystin-1, polycystin-2, polaris, and cystin, are co-localized in renal cilia.

Authors:  Bradley K Yoder; Xiaoying Hou; Lisa M Guay-Woodford
Journal:  J Am Soc Nephrol       Date:  2002-10       Impact factor: 10.121

10.  Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells.

Authors:  Surya M Nauli; Francis J Alenghat; Ying Luo; Eric Williams; Peter Vassilev; Xiaogang Li; Andrew E H Elia; Weining Lu; Edward M Brown; Stephen J Quinn; Donald E Ingber; Jing Zhou
Journal:  Nat Genet       Date:  2003-01-06       Impact factor: 38.330

View more
  10 in total

1.  Synergistic Genetic Interactions between Pkhd1 and Pkd1 Result in an ARPKD-Like Phenotype in Murine Models.

Authors:  Rory J Olson; Katharina Hopp; Harrison Wells; Jessica M Smith; Jessica Furtado; Megan M Constans; Diana L Escobar; Aron M Geurts; Vicente E Torres; Peter C Harris
Journal:  J Am Soc Nephrol       Date:  2019-08-19       Impact factor: 10.121

Review 2.  The primary cilium calcium channels and their role in flow sensing.

Authors:  Amanda Patel
Journal:  Pflugers Arch       Date:  2014-04-26       Impact factor: 3.657

3.  Ethanol's Effects on Transient Receptor Potential Channel Expression in Brain Microvascular Endothelial Cells.

Authors:  Sulie L Chang; Wenfei Huang; Xin Mao; Michelle L Mack
Journal:  J Neuroimmune Pharmacol       Date:  2018-07-09       Impact factor: 4.147

4.  Loss of primary cilia increases polycystin-2 and TRPV4 and the appearance of a nonselective cation channel in the mouse cortical collecting duct.

Authors:  Takamitsu Saigusa; Qiang Yue; Marlene A Bunni; P Darwin Bell; Douglas C Eaton
Journal:  Am J Physiol Renal Physiol       Date:  2019-07-17

5.  Ciliogenesis is reciprocally regulated by PPARA and NR1H4/FXR through controlling autophagy in vitro and in vivo.

Authors:  Zhi-Qiang Liu; Joon No Lee; Myeongjoo Son; Jae-Young Lim; Raghbendra Kumar Dutta; Yunash Maharjan; SeongAe Kwak; Goo Taeg Oh; Kyunghee Byun; Seong-Kyu Choe; Raekil Park
Journal:  Autophagy       Date:  2018-05-17       Impact factor: 16.016

Review 6.  Renal Ciliopathies: Sorting Out Therapeutic Approaches for Nephronophthisis.

Authors:  Marijn F Stokman; Sophie Saunier; Alexandre Benmerah
Journal:  Front Cell Dev Biol       Date:  2021-05-13

Review 7.  Recent advances in primary ciliary dyskinesia genetics.

Authors:  Małgorzata Kurkowiak; Ewa Ziętkiewicz; Michał Witt
Journal:  J Med Genet       Date:  2014-10-28       Impact factor: 6.318

Review 8.  microRNA biomarkers in cystic diseases.

Authors:  Yu Mi Woo; Jong Hoon Park
Journal:  BMB Rep       Date:  2013-07       Impact factor: 4.778

Review 9.  Kidney disease models: tools to identify mechanisms and potential therapeutic targets.

Authors:  Yin-Wu Bao; Yuan Yuan; Jiang-Hua Chen; Wei-Qiang Lin
Journal:  Zool Res       Date:  2018-03-18

Review 10.  An Overview of In Vivo and In Vitro Models for Autosomal Dominant Polycystic Kidney Disease: A Journey from 3D-Cysts to Mini-Pigs.

Authors:  Svenja Koslowski; Camille Latapy; Pierrïck Auvray; Marc Blondel; Laurent Meijer
Journal:  Int J Mol Sci       Date:  2020-06-25       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.